FDA Grants Priority Review to Sodium Thiosulfate for Ototoxicity Prevention

The FDA granted priority review to the new drug application for sodium thiosulfate for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to<18 years of age with localized, non-metastatic, solid tumors.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news